Home » Dexcom’s Glucose Monitoring System Receives FDA Approval
Dexcom’s Glucose Monitoring System Receives FDA Approval
The FDA gave Dexcom’s continuous glucose monitoring system Dexcom G6 marketing approval and classified the product as a Class II device.
The Dexcom G6 can integrate with other medical devices and electronic interfaces like insulin pumps, blood glucose meters and automated insulin dosing systems.
The device is a small patch that users apply to their abdomen. A sensor within the device continuously measures glucose in the user’s body fluid and transmits readings every five minutes to its smartphone app.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May